Target intelligence / Profile preview

FSHD region gene 2 family member B (FRG2B)

Target
FRG2B
Molecular classification
Other (long noncoding RNA gene family/paralog; not a receptor, enzyme, transporter, or typical drug target)
01

Overview

FRG2B (FSHD region gene 2 family member B) encodes a paralog of the FRG2 gene and is predicted primarily to produce noncoding RNAs highly similar to FRG2A, contributing to chromatin structure and nucleolar organization rather than classical protein function[1][2][5]. FRG2B transcript is enriched in the nucleus and is associated with heterochromatin, with a nucleolar sub-compartment localization. FRG2B, together with its paralogs, is thought to contribute to nuclear architecture as a scaffold for heterochromatin interactions with nucleolar periphery and has been investigated in the context of neuromuscular disease, especially as part of a locus altered in facioscapulohumeral muscular dystrophy. There is no definitive evidence supporting its role as a traditional therapeutic target, nor is there evidence of direct drug interactions or use as a biomarker.

Other names
Protein FRG2-like-1HSA10-FRG2FSHD region gene 2 protein family member BFRG2B
02

Biological functions

Associated with heterochromatinlikely regulatory function in nuclear architecture and nucleolar organization
03

Disease associations

Other (expression studied in the context of facioscapulohumeral muscular dystrophy, FSHD)

Beyond the preview

Go deeper on FSHD region gene 2 family member B (FRG2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSHD region gene 2 family member B (FRG2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call